Claim Pending

biotech revenues will grow by at least 12% in 2026

Ernst & Young: biotech revenues will grow by at least 12% in 2026 Published Jun 9, 2026. Status: Pending. biotech revenue growth rate in 2026

• Actor: Ernst & Young
• Topic: Science
• Status: Pending
• Published: Jun 9, 2026
• Deadline: Dec 31, 2026

biotech revenues will grow by at least 12% in 2026